Use of Patent Information to Characterize Trends in the Therapeutic Applications of Extracellular Vesicles Derived from Mesenchymal Stem Cells (MSC-EVs)

Ángela      Ponce-Polo; Alvaro   Ritoré   Hidalgo; Arturo   Argüello   Martínez; Roke   Iñaki Oruezabal   Guijarro

doi:10.2174/1872208316666220303095217

Abstract

Extracellular vesicles derived from mesenchymal stromal cells (MSC-EVs) are gaining interest for medical purposes. The promising therapeutic effects exhibited in both preclinical and clinical studies have suggested that they may become an alternative for certain applications to cell-based therapies, which are subjected to stricter regulations. The commercial exploitation of these candidates requires a proper patent strategy from both the industry and public research organizations. Here, we performed a global patent literature analysis to identify key players and therapeutic applications in the field. Our results showed an increasing rate of patent publications since 2009, with Asia (specifically China) leading the patenting activity. The therapeutic use of MSC-EVs within patent literature covers a wide range of diseases, in which “Dermal and Wounds,” “Neurology” and “Cardiovascular” are the main therapeutic areas. Moreover, most of these patents include “productby- process” claims, since the therapeutic effects of MSC-EVs could be influenced by their manufacturing process. Our results followed scientific and clinical literature trends.

Keywords: Patents, therapeutic use, extracellular vesicles, exosomes, mesenchymal stromal cells, mesenchymal stem cells.

« Previous Next »

Graphical Abstract

[1] 
Roy S, Hochberg FH, Jones PS. Extracellular vesicles: The growth as diagnostics and therapeutics; a survey. J Extracell Vesicles  2018; 7(1): 1438720.
[http://dx.doi.org/10.1080/20013078.2018.12438720] [PMID:  29511461] 
[2] 
Wang Y, Wang Q, Wei X, et al. Global scientific trends on exosome research during 2007-2016: A bibliometric analysis. Oncotarget  2017; 8(29): 48460-70.
[http://dx.doi.org/10.18632/oncotarget.17223] [PMID:  28477015] 
[3] 
Aheget H, Tristán-Manzano M, Mazini L, et al. Exosome: A new player in translational nanomedicine. J Clin Med  2020; 9(8): 2380.
[http://dx.doi.org/10.3390/jcm9082380] [PMID:  32722531] 
[4] 
Aiello A, Giannessi F, Percario ZA, Affabris E. An emerging interplay between extracellular vesicles and cytokines. Cytokine Growth Factor Rev  2020; 51(51): 49-60.
[http://dx.doi.org/10.1016/j.cytogfr.2019.12.003] [PMID:  31874738] 
[5] 
Lener T, Gimona M, Aigner L, et al. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles  2015; 4(1): 30087.
[http://dx.doi.org/10.3402/jev.v4.30087] [PMID:  26725829] 
[6] 
van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol  2018; 19(4): 213-28.
[http://dx.doi.org/10.1038/nrm.2017.125] [PMID:  29339798] 
[7] 
Di Rocco G, Baldari S, Toietta G. Towards therapeutic delivery of extracellular vesicles: Strategies for in vivo tracking and biodistribution analysis. Stem Cells Int  2016; 2016: 5029619.
[PMID: 27994623] 
[8] 
Elahi FM, Farwell DG, Nolta JA, Anderson JD. Preclinical translation of exosomes derived from mesenchymal stem/stromal cells. Stem Cells  2020; 38(1): 15-21.
[http://dx.doi.org/10.1002/stem.3061] [PMID:  31381842] 
[9] 
Martin-Rufino JD, Espinosa-Lara N, Osugui L, Sanchez-Guijo F. Targeting the immune system with mesenchymal stromal cell-derived extracellular vesicles: What is the cargo’s mechanism of action? Front Bioeng Biotechnol  2019; 7: 308.
[http://dx.doi.org/10.3389/fbioe.2019.00308] [PMID:  31781552] 
[10] 
Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells  2017; 35(4): 851-8.
[PMID: 28294454] 
[11] 
Yin K, Wang S, Zhao RC. Exosomes from mesenchymal stem/stromal cells: A new therapeutic paradigm. Biomark Res  2019; 7(1): 8.
[http://dx.doi.org/10.1186/s40364-019-0159-x] [PMID:  30992990] 
[12] 
Keshtkar S, Azarpira N, Ghahremani MH. Mesenchymal stem cell-derived extracellular vesicles: Novel frontiers in regenerative medicine. Stem Cell Res Ther  2018; 9(1): 63.
[http://dx.doi.org/10.1186/s13287-018-0791-7] [PMID:  29523213] 
[13] 
Ren K. Exosomes in perspective: A potential surrogate for stem cell therapy. Odontology  2019; 107(3): 271-84.
[http://dx.doi.org/10.1007/s10266-018-0395-9] [PMID:  30324571] 
[14] 
Stapleton S. Exosomes as therapeutics and drug delivery vehicles  Global regulatory perspectives. Cell Gene Ther Insights  2020; 6(11): 1561-9.
[http://dx.doi.org/10.18609/cgti.2020.172] 
[15] 
Zhao AG, Shah K, Cromer B, Sumer H. Mesenchymal stem cell-derived extracellular vesicles and their therapeutic potential. Stem Cells Int  2020; 2020: 8825771.
[http://dx.doi.org/10.1155/2020/8825771] 
[16] 
Massa M, Croce S, Campanelli R, et al. Clinical applications of mesenchymal stem/stromal cell derived extracellular vesicles: Therapeutic potential of an acellular product. Diagnostics (Basel)  2020; 10(12): 999.
[http://dx.doi.org/10.3390/diagnostics10120999] [PMID:  33255416] 
[17] 
Maumus M, Rozier P, Boulestreau J, Jorgensen C, Noël D, Martin I. Mesenchymal stem cell-derived extracellular vesicles: Opportunities and challenges for clinical translation. Front Bioeng Biotechnol  2020; 8(September): 997.
[http://dx.doi.org/10.3389/fbioe.2020.00997] [PMID:  33015001] 
[18] 
Cai J, Wu J, Wang J, et al. Extracellular vesicles derived from different sources of mesenchymal stem cells: Therapeutic effects and trans-lational potential. Cell Biosci  2020; 10(1): 69.
[http://dx.doi.org/10.1186/s13578-020-00427-x] [PMID:  32483483] 
[19] 
Shekari F, Nazari A, Assar Kashani S, Hajizadeh-Saffar E, Lim R, Baharvand H. Pre-clinical investigation of mesenchymal stromal cell-derived extracellular vesicles: A systematic review. Cytotherapy  2021; 23(4): 277-84.
[http://dx.doi.org/10.1016/j.jcyt.2020.12.009] [PMID:  33541780] 
[20] 
Clinicaltrials.gov. Database.  2021. Available from: https://www.clinicaltrials.gov/ct2/home
[21] 
Quiñones-Vico MI, Sanabria-de la Torre R, Sánchez-Díaz M, et al. The role of exosomes derived from mesenchymal stromal cells in der-matology. Front Cell Dev Biol  2021; 9: 647012.
[http://dx.doi.org/10.3389/fcell.2021.647012] [PMID:  33898436] 
[22] 
Espacenet Database. 2021.Available from: https://worldwide.espacenet.com/
[23] 
Chang BC, Wang SJ. The limited benefit of “product-by-process” claim. Hum Vaccin Immunother  2016; 12(10): 2685-7.
[http://dx.doi.org/10.1080/21645515.2016.1185211] [PMID:  27441574] 
[24] 
Walker S, Busatto S, Pham A, et al. Extracellular vesicle-based drug delivery systems for cancer treatment. Theranostics  2019; 9(26): 8001-17.
[http://dx.doi.org/10.7150/thno.37097] [PMID:  31754377] 
[25] 
Corrêa RR, Juncosa EM, Masereeuw R, Lindoso RS. Extracellular vesicles as a therapeutic tool for kidney disease: Current advances and perspectives. Int J Mol Sci  2021; 22(11): 5787.
[http://dx.doi.org/10.3390/ijms22115787] [PMID:  34071399] 
[26] 
Hongda B, Haiying D, Shuo F, et al. MiRNA145-5p-modified
  umbilical cord mesenchymal stem cell exosome and preparation
  and application of miRNA145-5p-modified umbilical cord mesenchymal stem cell exosome : CN105483081A.2016.
[27] 
Bo B, Gingli B, Zhi C, Haixin D, et al. Wnt4/YWHAZ co-modified
  mesenchymal stem cell (MSC) derived exosome, preparation method therefor and application of Wnt4/YWHAZ co-modified MSC
 derived exosome : CN110734896A.2020.
[28] 
Zhu L, Ping S, Yunpeng T. Stem cell exosome capable of repairing
  skin as well as preparation method and application thereof : CN108837142A.2018.
[29] 
Kwon You S, Jung-Hyun P, Ji-Hoon J, Eun Kyoung J. Method for
  preparing composition, included within exosome obtained from
  nanog-introduced, fetus-derived mesenchymal stem cell in amniotic
  fluid, for hair growth : EP3569239A2.2019.
[30] 
Kyung Sun K, Kwang Won S, Yu Lee K, Yoon Jin K. Stem cellderived exosomes containing a high amount of growth factors : US2019133922A1.2019.
[31] 
Wook CE, Su K, Jong LW, Joo PE, Koo SM, Young WE. Composition for improving skin and preventing hairloss and method for
 preparing the same : KR 20180127280A.2018.
[32] 
Hyung-Sik K, Tae-Yoon K. Novel use of extracellular vesicles
 derived from stem cells in which sod3 is overexpressed. : WO2020085533A1.2020.
[33] 
Seung CB, Weon YY. New use of exosome kit comprising stem
 cell-derived exosome : WO 2019050240A1.2019.
[34] 
Yanyun L, Yanfang L, Bihua L, Weiqing Y, Ziyu Y, Jincheng Z. Gingival mesenchymal stem cell exosome preparation and application thereof. CN 111135190 2020.
[35] 
Evangelos B. Methods and compositions for the treatment of epidermolysis bullosa : WO2019060719A1.2019.
[36] 
Kalani A, Tyagi N. Exosomes in neurological disease, neuroprotection, repair and therapeutics: Problems and perspectives. Neural Regen Res  2015; 10(10): 1565-7.
[http://dx.doi.org/10.4103/1673-5374.165305] [PMID:  26692841] 
[37] 
Ochiya T. Pharmaceutical product for preventing or treating Alzheimer’s disease : EP2756847A1.2014.
[38] 
Yang L, Cheng G, Zhai Y, Zhu Z. Three-dimensionally cultured
 mesenchymal stem cells derived exosomes and preparation method
 and application thereof : CN109913409A.2019.
[39] 
Yang C, Sun S, Peng Y, Zhang Q, Guo J, Yang M. Exosome and
 preparing method and application thereof : CN109777770A.2019.
[40] 
Khoury M, Wyneken U, Lopez MA. Neurite regeneration therapy
 based on exosomes derived from menstrual stem cells : WO2017064688A1.2017.
[41] 
Yang C, Sun S, Zhang Q, et al. Exosomes of antler mesenchymal stem cells improve postoperative cognitive dysfunction in cardiopulmo-nary bypass rats through inhibiting the TLR2/TLR4 signaling pathway. Stem Cells Int  2020; 2020: 2134565.
[http://dx.doi.org/10.1155/2020/2134565] [PMID:  32300366] 
[42] 
Zhang ZG, Xiong Y, Chopp M. 3-D Collagen scaffold-generated
exosomes and uses thereof. : US2019060367A1.2019.
[43] 
Levenberg S, Guo S, Offen D, Perets N. Vesicles comprising a pten
inhibitor and uses of same. : WO2019186558A1.2019.
[44] 
Bang Oh Y, Hee KE, Cha Jae M. Stem cell-derived microvesicles
 with enhanced efficacy use thereof and method for enhancing efficacy. : KR20200047330A.2020.
[45] 
Chang YS. Park W soon, Ahn So Y, Sung Dong K. Composition
 for treating neonatal hie. : EP3569238A12019.
[46] 
Zhang Z, Zhang Y, Chopp M. Compositions for the treatment of
 neuropathic pain and sensitization of tumors to chemotherapies.
  : US2019175661A1.2019.
[47] 
Zhao K. Making technology of exosome spray capable of preventing brain damage caused by epilepsy. : CN110721198A,.2020.
[48] 
Hade MD, Suire CN, Suo Z. Mesenchymal stem cell-derived exosomes: Applications in regenerative medicine. Cells  2021; 10(8): 1959.
[http://dx.doi.org/10.3390/cells10081959] [PMID:  34440728] 
[49] 
Chengyu M, Changqian W. Intermittent hypoxia treated stem cell
 derived exosome and application in cardiac muscle tissue.
  : CN110577931A.2019.
[50] 
Yuejin Y, Peisen H, Guihao C. Method for preparing mesenchymal
 stem cell-derived exosomes on basis of drug pretreatment.
 : EP3663394A1,.2020.
[51] 
Liang C, Hai H, Wei L, Yi Z. Preparation method and application
 of mesenchymal stem cell exosome. : CN108624557A.2018.
[52] 
Yifeng B, Yifei D, Xiaojie M, Yuli W, Hua Y. Method for extracting exosome from amniotic mesenchymal stem cells and application of exosome. : CN110904037A.2020.
[53] 
Heydari R, Abdollahpour-Alitappeh M, Shekari F, Meyfour A. Emerging role of extracellular vesicles in biomarking the gastrointestinal diseases. Expert Rev Mol Diagn  2021; 21(9): 939-62.
[http://dx.doi.org/10.1080/14737159.2021.1954909] [PMID:  34308738] 
[54] 
Yanchun Y. Application of exosome to preparing of acute-hepaticfailure treating medicine and medicine composition. : CN105535022A.2016.
[55] 
 Gail e B, Yu Z.. Methods of delivering heparin binding epidermal
 growth factor using stem cell generated exosomes. US
 : 2017173113A1.2017.
[56] 
Haijia C, Xiaohu G, Ruishan L, Xiaoyan W, Yifei W. Stem cell
 exosome preparation, and preparation method and application
 thereof.  : CN 106492194 A.2017.
[57] 
Xie X, Xiong Y, Panayi AC, et al. Exosomes as a novel approach to reverse osteoporosis: A review of the literature. Front Bioeng Biotechnol  2020; 8: 594247.
[http://dx.doi.org/10.3389/fbioe.2020.594247] [PMID:  33195163] 
[58] 
Cho YW, Lee KS, Choi JS. Composition for preventing or treating
osteoporosis containing exosomes extracted from stem cells as active ingredient. : EP3659611A2.2020.
[59] 
Ludlow J, Buehrer B, Pieraccini P. Exosome compositions and use
 thereof for joint disorders and diseases. : WO2019139762A1.2019.
[60] 
Ma Y, Jung HG.  Immunosuppressive cell preparation as well as
 preparation method and application thereof. : CN107519207A.2017.
[61] 
Cho YW, Choi JS, Woo CH, Choi YC, Jo DG. Composition for
 chondrocyte differentiation induction or cartilage tissue regeneration, containing exosomes extracted from stem cells differentiating
 into chondrocytes. : WO2016126122A2,.2019.
[62] 
Sun HB. Stem cell-produced microvesicles for treating tendon
 pathologies. : WO2018039100A3.2018.
[63] 
Yang R. Mesenchymal stem cell exosome preparation and application thereof. : CN110403959A.2019.
[64] 
Lin J, Huang J, Cai R, Kuang Y. Method for preparing adiposederived stem cell exosomes, adipose-derived stem cell exosomes
 and application thereof. : CN109943533A.2019.
[65] 
Zhang B, Lu Z, Hong J. Sustained-release microsphere containing
 exosomes of mesenchymal stem cells and preparation method
 thereof. : CN109172606A.2019.
[66] 
Zhang B, Han H, Lu Z, Mou X, Xu Y. Stem cell exosome concentrated solution gel preparation for treating erectile dysfunction
(ED), and preparation method and administration method of stem
 cell exosome concentrated solution gel preparation.
 : CN109893542A.2019.
[67] 
Zhang B, Lu Z, Hong J.  A kind of injection of the excretion of
 mescenchymal stem cell containing endometrium body.
  : CN109078021A.2019.
[68] 
Hou Y, Song Y, Ni Y, Fan H, Zhao X, Zhao S. Application of mesenchymal stem cell-derived exosome in preparing drug or preparation for treating preeclampsia. : CN105769916A.2016.
[69] 
Von Schulze A, Deng F. A review on exosome-based cancer therapy. J Cancer Metastasis Treat  2020; 6: 42.
[70] 
Cantaluppi V, Deregibus m c a, Khamse G.  Application of stemcell-derived microvesicles (MVs) in preparing medicine used in
 damaged or injured tissue or organ endothelial/epithelial regeneration, and related in-vitro and in-vivo methods. : CN103211839A.2013.
[71] 
Brodie A, Brodie C. MSC-and exosome-based immunotherapy.
 : WO2020016900A1.2020.
[72] 
Wang L, Zhang Y, Xu M. Exosome serving as mesenchymal stem
 cell source and having anti-cancer effect and medicinal preparation
 thereof. : CN106974938A.2017.
[73] 
Hong S, Park S-J. Dendrimer-exosome hybrid nanoparticles as a
 delivery platform. : US2018369410A1,.2018.
[74] 
Kim JH, Choi YJ. Composition for preventing or treating cancer
 comprising exosome derived from stem cells. : KR101820264B1.2018.
[75] 
Institute National Cancer. 2021.Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pulmonary-disease
[76] 
Lee KY, Ito K, Maneechotesuwan K. Inflammation to pulmonary diseases. Mediators Inflamm  2016; 2016: 7401245.
[http://dx.doi.org/10.1155/2016/7401245] [PMID:  27293320] 
[77] 
Yousefi Dehbidi M, Goodarzi N, Azhdari MH, Doroudian M. Mesenchymal stem cells and their derived exosomes to combat Covid-19. Rev Med Virol 2021.: e2281.
[http://dx.doi.org/10.1002/rmv.2281] [PMID:  34363275] 
[78] 
Yong B, Guangju J, Zhiguang Y. Application of mesenchymal stem
 cell exosome to preparation of medicament for preventing and treating radiation-induced lung injury (RILI). : CN109432130A.2019.
[79] 
Liu M, Xu J. Application of MSC (mesenchymal stem cell) exosomes in preparation of pharmaceutic preparation for treating PF
 (pulmonary fibrosis). : CN104666344A.2015.
[80] 
Cho YW, Choi JS, Yeom SH, Jung YJ. Composition for preventing
 or treating pulmonary fibrosis including exosome extracted from
 adipose-derived stem cell as active component. : EP3494977A1.2019.
[81] 
Jingyu G, Hongqi H, Wenjing H. Silicosis treatment aerosol containing human mesenchymal stem cell exosome extract and preparation method thereof. : CN107137426A.2017.
[82] 
Gang G, Xuchun H, Guofeng H. Electronic cigarette tobacco liquid
 containing stem cell exosome and preparation method and application thereof. : CN 107510098 A.2017.
[83] 
Trademarks and patents in China : The impact of non-market factors on filing trends and IP systems United States Patent and
 Trademark Office (UPSTO) 2021.
[84] 
Ibrahim S, Khan Y. Histology, extracellular vesicles In. StatPearls Treasure Island (FL)  2021.

Rights & Permissions Print Cite

Article Metrics

19

1

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1872208316666220303095217	Print ISSN 1872-2083
Publisher Name Bentham Science Publisher	Online ISSN 2212-4012

Recent Patents on Biotechnology

Use of Patent Information to Characterize Trends in the Therapeutic Applications of Extracellular Vesicles Derived from Mesenchymal Stem Cells (MSC-EVs)

Abstract Play Pause

Graphical Abstract

Related Journals

Related Books

Abstract